Crossmark

Clinical evaluation of a resurfacing device implant for femoral osteochondral defects greater than 1 cm2 with a minimal follow-up of 4 years: a prospective cohort study

Crossref DOI link: https://doi.org/10.1007/s00590-023-03613-y

Published Online: 2023-06-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bouché, Pierre-Alban https://orcid.org/0000-0002-4117-4651
Fiodière, Valerian

Kierszbaum, Elliott

Ehkirch, François-Paul
License Information

Text and Data Mining valid from 2023-06-10

Version of Record valid from 2023-06-10
More Information

Article History

Received: 14 May 2023

Accepted: 1 June 2023

First Online: 10 June 2023

Declarations

:

: No conflicts of interest.

: This study was approved by the research ethics committee of <i>Maussins Clinics</i> under the reference N° <i>Maus-2020-11-01</i>.

: All patients gave their consent to participate to the study. All authors gave their consent to publish the study.

Document is current

Any future updates will be listed below